Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Vaccines in the era of genomics: the pneumococcal challenge.

Barocchi MA, Censini S, Rappuoli R.

Vaccine. 2007 Apr 20;25(16):2963-73. Epub 2007 Jan 30. Review.

PMID:
17324490
3.

Advances in pneumococcal vaccines: what are the advantages for the elderly?

Vila-Córcoles A.

Drugs Aging. 2007;24(10):791-800. Review.

PMID:
17896829
4.

Developing antibacterial vaccines in genomics and proteomics era.

Kaushik DK, Sehgal D.

Scand J Immunol. 2008 Jun;67(6):544-52. doi: 10.1111/j.1365-3083.2008.02107.x. Epub 2008 Apr 4. Review.

5.

Confronting the pneumococcus: a target shift or bullet change?

Obaro SK.

Vaccine. 2000 Dec 8;19(9-10):1211-7. Review.

PMID:
11137259
6.

Genome-based approaches to develop vaccines against bacterial pathogens.

Serruto D, Serino L, Masignani V, Pizza M.

Vaccine. 2009 May 26;27(25-26):3245-50. doi: 10.1016/j.vaccine.2009.01.072. Epub 2009 Feb 5. Review.

PMID:
19200820
7.
8.

Pneumococcal conjugated vaccines: impact of PCV-7 and new achievements in the postvaccine era.

Dinleyici EC, Yargic ZA.

Expert Rev Vaccines. 2008 Nov;7(9):1367-94. doi: 10.1586/14760584.7.9.1367. Review.

PMID:
18980540
9.

Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.

Pletz MW, Maus U, Krug N, Welte T, Lode H.

Int J Antimicrob Agents. 2008 Sep;32(3):199-206. doi: 10.1016/j.ijantimicag.2008.01.021. Epub 2008 Apr 18. Review.

PMID:
18378430
10.

Pneumococcal conjugate vaccines. A review.

Galiza EP, Heath PT.

Minerva Med. 2007 Apr;98(2):131-43. Review.

PMID:
17519855
11.

The use of genomics in microbial vaccine development.

Bambini S, Rappuoli R.

Drug Discov Today. 2009 Mar;14(5-6):252-60. doi: 10.1016/j.drudis.2008.12.007. Epub 2009 Jan 15. Review.

PMID:
19150507
12.

Combat pneumococcal infections: adhesins as candidates for protein-based vaccine development.

Gamez G, Hammerschmidt S.

Curr Drug Targets. 2012 Mar;13(3):323-37. Review.

PMID:
22206255
13.

Pneumococcal polysaccharide protein D-conjugate vaccine (Synflorix; PHiD-CV).

Croxtall JD, Keating GM.

Paediatr Drugs. 2009;11(5):349-57. doi: 10.2165/11202760-000000000-00000. Review.

PMID:
19725600
14.
15.

Pneumococcal vaccine in the elderly: a useful but forgotten vaccine.

Chidiac C, Ader F.

Aging Clin Exp Res. 2009 Jun;21(3):222-8. Review.

PMID:
19571646
16.

Developing vaccines in the era of genomics: a decade of reverse vaccinology.

Seib KL, Zhao X, Rappuoli R.

Clin Microbiol Infect. 2012 Oct;18 Suppl 5:109-16. doi: 10.1111/j.1469-0691.2012.03939.x. Epub 2012 Aug 6. Review.

17.

Pneumococcal vaccination in adults: recommendations, trends, and prospects.

Targonski PV, Poland GA.

Cleve Clin J Med. 2007 Jun;74(6):401-6, 408-10, 413-4. Review.

PMID:
17569198
18.

The transforming Streptococcus pneumoniae in the 21st century.

Hsieh YC, Lee WS, Shao PL, Chang LY, Huang LM.

Chang Gung Med J. 2008 Mar-Apr;31(2):117-24. Review.

19.

The genome revolution in vaccine research.

Capecchi B, Serruto D, Adu-Bobie J, Rappuoli R, Pizza M.

Curr Issues Mol Biol. 2004 Jan;6(1):17-27. Review.

20.

The coming of age of niche vaccines? Effect of vaccines on resistance profiles in Streptococcus pneumoniae.

McGee L.

Curr Opin Microbiol. 2007 Oct;10(5):473-8. Epub 2007 Oct 23. Review.

PMID:
17936680

Supplemental Content

Support Center